An act relating to reducing overdoses

This bill reduces overdose risks in Vermont by expanding access to buprenorphine treatment, legalizing drug-checking services, and creating a dedicated funding stream for opioid prevention. It allows healthcare providers to prescribe up to 24 milligrams of buprenorphine without prior authorization, permits community organizations to test substances for contaminants without fear of legal penalties, and establishes an Opioid Abatement Special Fund to finance naloxone distribution and treatment programs. The legislation also clarifies that drug-checking results cannot be used as evidence in court and ensures that individuals seeking these services face no arrest or prosecution for possession of the substances being tested.